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Complementary and alternative medicine (CAM) is increasingly being integrated into con-
ventional medical care for cancer, used to counter the side effects of conventional cancer
treatment, and offered as an alternative to conventional cancer care. Our aim is to gain a
broader understanding of trends in CAM interventions for cancer and crowdfunding cam-
paigns for these interventions.
Methods
GoFundMe campaigns fundraising for CAM were retrieved through a database of crowd-
funding campaign data. Search terms were drawn from two National Institutes of Health lists
of CAM cancer interventions and a previous study. Campaigns were excluded that did not
match these or related search terms or were initiated outside of June 4th, 2018 to June 4th,
2019.
Results
1,396 campaigns were identified from the US (n = 1,037, 73.9%), Canada (n = 165, 11.8%),
and the UK (n = 107, 7.7%). Most common cancer types were breast (n = 344, 24.6%), colo-
rectal (n = 131, 9.4%), and brain (n = 98, 7.0%). CAM interventions sought included supple-
ments (n = 422, 30.2%), better nutrition (n = 293, 21.0%), high dose vitamin C (n = 276,
19.8%), naturopathy (n = 226, 16.2%), and cannabis products (n = 211, 15.1%). Mexico (n =
198, 41.9%), and the US (n = 169, 35.7%) were the most common treatment destinations.
Conclusions
These findings confirm active and ongoing interest in using crowdfunding platforms to
finance CAM cancer interventions. They confirm previous findings that CAM users with can-
cer tend to have late stage cancers, cancers with high mortality rates, and specific diseases
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such as breast cancer. These findings can inform targeted responses where facilities
engage in misleading marketing practices and the efficacy of interventions is unproven.
Introduction
Complementary and alternative medicine (CAM) is made up of medical products and prac-
tices that are not part of conventional medical practice and care [1, 2]. However, CAM is
increasingly being integrated into conventional medical care for cancer, used to counter the
side effects of conventional cancer treatment, and offered as an alternative to conventional
cancer care [3]. Despite the growing popularity, the studies on the safety and efficacy of CAM
cancer interventions are mixed and have tended to be of poor quality [4, 5]. At the same time,
use of CAM cancer treatments is associated with significant potential harms [6]. In some
cases, CAM treatments can interfere with the functioning of conventional treatments [3]. Peo-
ple seeking CAM cancer treatments are also more likely to refuse conventional cancer treat-
ment [7]. This is concerning as delaying or refusing to use conventional cancer treatments in
favour of CAM treatments can reduce cancer survival rates [8].
In addition to potentially reducing the survivability of cancer, use of CAM can harm other
aspects of wellbeing. When CAM interventions are ineffective or less effective than expected,
they can lead to significant financial costs to users. CAM modalities for cancer treatment are
often paid for out-of-pocket and add up to $445 per person utilizing them or $6.7 billion annu-
ally in the United States (US) [9]. Moreover, misinformation about the safety and efficacy of
CAM treatments for cancer is common and can create false hope about the likely effects of
these interventions [10]. Despite these concerns, some view the increased use of CAM for can-
cer as a result of the weaknesses of conventional cancer care, including an unjustified tolera-
tion of misinformation by some CAM providers, poor management of the negative side effects
of conventional treatment, inadequate access to palliative care, and the patriarchal structure of
conventional medicine [11, 12].
There are significant challenges to understanding trends in how CAM is used due to scar-
city of data and hesitancy of patients to disclose some CAM use to their physicians [8]. Studies
in the US have found that 79% of cancer survivors used a CAM modality in the previous year,
most commonly vitamins and minerals (74.8%), non-vitamin and mineral natural products
(23.7%), manipulative and body-based therapies including chiropracty and massage (18.6%),
homeopathy (2.9%), acupuncture (2.0%), naturopathy (1.0%), and energy healing (0.9%) [9].
Other studies have found the mean percentage of people with cancer using CAM globally to be
51% [3]. Those using alternative treatments in lieu of conventional treatment are more likely
to be female, at a higher cancer stage, young, better educated, and wealthier than the general
population of people with cancer [3, 8, 9, 13, 14]. People with breast, melanoma, or colorectal
cancer have been found to be more likely to seek CAM than those with prostate cancer [7, 9].
Because CAM cancer treatments are often not paid for by public or private insurance, indi-
viduals desiring to pursue these treatments can face significant out of pocket costs. As a result,
a growing number of people seek financial support from friends, family, and even strangers
through online crowdfunding, including for CAM cancer treatments [15, 16]. These cam-
paigns include user-generated accounts of their cancer diagnosis, CAM treatments sought,
and providers of CAM interventions. For example, one study of crowdfunding campaigns for
people with cancer seeking homeopathic treatments found that these recipients also sought
CAM treatments including food and diet changes, natural supplements, vitamins and
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minerals, oxygen and ozone therapies, cannabis-based treatments, energy healing, and hyper-
thermia [17]. As such, these campaigns have the potential to offer valuable and timely informa-
tion on trends in CAM cancer interventions. This data can also provide an understanding of
CAM usage by people with cancer that complements existing data obtained from physicians
and in a clinical setting.
Many recipients of crowdfunding campaigns for CAM interventions choose to forgo con-
ventional treatment or palliative care. These recipients are often very ill, as demonstrated in
one study where at least 28% of recipients had died following the start of their campaign [17].
The use of crowdfunding for CAM cancer interventions also raises distinct concerns because
these campaigners may seek CAM treatments with little to no evidentiary support, directing
money from large pools of people to clinics with problematic business practices. Previous anal-
yses of these campaigns have flagged the Burzynski clinic in Texas, the Hallwang Private
Oncology Clinic in Germany, and providers selling the Gerson therapy as a cancer treatment
as engaging in misleading marketing or selling products that may put patients at risk [15].
Moreover, studies of crowdfunding campaigns for alternative or unproven interventions have
found that these campaigners often repeat and exaggerate misinformation about the safety and
efficacy of these interventions, use markers of scientific legitimacy to support their campaigns,
and are used to fund ineffective and potentially dangerous interventions [18–21]. This is not
surprising given that these campaigns must reassure potential donors of the value of these
interventions and that their money will be well spent. But in doing so, these campaigns poten-
tially spread misinformation about CAM and unproven treatments to a large audience.
Thus, it is important to gain a broader understanding of the dimensions of crowdfunding
campaigns for CAM cancer treatments both as an insight into developing trends in demand
for these interventions generally and to better understand their scope in crowdfunding cam-
paigns specifically.
Methods
The GoFundMe crowdfunding platform was selected to identify crowdfunding campaigns for
CAM cancer interventions as this is by far the largest host of medical crowdfunding campaigns
globally [22]. GoFundMe.com campaigns fundraising for CAM treatments were retrieved
through a database of scraped crowdfunding campaign data that records all campaign text but
does not include images and video. This database is a searchable collection of all GoFundMe.
com campaigns on the website that began recording campaign data in April, 2019. Ethics
approval was not required for the use of this data as it is publicly available without an expecta-
tion of privacy. Recorded data includes the campaign title, amount pledged, amount requested,
campaign type category, fundraiser location, Facebook shares, campaign description, and
updates. Each search conducted on the portal is exported as a CSV file.
To identify search terms for CAM cancer campaigns, we utilized two National Institutes of
Health (NIH) lists of CAM cancer treatments and treatment types and a list of CAM treatment
types identified in a previous study of crowdfunding for CAM cancer interventions [17, 23,
24]. From these sources, 123 CAM interventions were identified. After identification of these
search terms, the authors reviewed the included search terms and recommended removing
CAM treatments that are common foods, such as vegetables, or that were health oriented
behaviours that were too broadly framed to be considered as solely alternative in nature, such
as exercise. The authors additionally identified similar terms and labels for each identified
CAM treatment to identify alternative language used by crowdfunders to fundraise (for exam-
ple, cannabis synonyms include marijuana and cannabidiol). After the authors agreed upon
the search terms, 110 CAM treatments and their identified related terms were searched on the
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database with the word “cancer” (see S1 Appendix). The search was conducted from June 9 –
July 25, 2019 and identified campaigns for each individual search were recorded on individual
spreadsheets.
These searches yielded a total of 16,506 campaigns. After duplicate campaigns were
removed, there were 10,619 campaigns. Campaign categories irrelevant to those funding for
medical purposes were removed, including: animals, business, California fire, Canada 150,
competitions, creative, education, Hurricane Maria, memorials, Nepal, newlyweds, sports, vol-
unteer, and wishes. The campaign categories included, which are applicable to those fundrais-
ing for medical reasons, are: cancer, charity, community, emergencies, events, faith, family,
medical, other, travel, and blank. The exclusion of campaign categories irrelevant to medical
purposes reduced the number of campaigns to 9,326.
A one-year campaign launch time range of June 4th, 2018 to June 4th, 2019 was imple-
mented to create a dataset of a manageable size, leaving 2,904 campaigns. These campaigns
were organized in a spreadsheet and split for review between the first and second author. Cam-
paigns were included only if a CAM intervention matching the search terms or related to these
terms was sought for cancer. The third author reviewed 5% of these campaigns during the
review process to verify consistent application of inclusion and exclusion criteria and disagree-
ments were discussed and resolved by the authors. A total of 1,396 campaigns met this inclu-
sion criterion and had their campaign characteristics recorded and tabulated. Recorded data
included the stage of cancer, cancer type, CAM treatment(s), provider(‘s) location(s), and pro-
vider(‘s) name(s).
Results
These 1,396 campaigns were supported by 122,701 (median 49) donors and shared on Face-
book 577,351 (median 234) times. They requested $39,611,973.20 (median $19,880) and were
pledged $12,756,563.92 (median $5,055.50) or 32.2% of that amount. 1,037 (73.9%) of these
campaigners were from the US, 165 (11.8%) from Canada, 107 (7.7%) from the UK, and 57
(4.1%) from Australia. Of the remaining campaigns, 28 (2%) were from Europe, 2 from Japan,
and 1 each from Costa Rica, the Dominican Republic, Mauritius, Panama, and the Philippines
(see Table 1) (see Figs 1–3). When recipients’ cancer stage was described, these skewed toward
late stage cancers, including stage 4 (n = 454, 55.8%), stage 3 (n = 130, 16.0%), and cancers
described as metastatic or late stage (n = 102, 12.5%) or terminal or incurable (n = 79, 9.7%).
The remaining campaigns identified stage 2 (n = 42, 5.2%) and stage 1 (n = 7, 0.9%) cancer
diagnoses (see Table 2).
The recipients of these campaigns were described as having a broad range of cancer types.
By far the most common of these was breast cancer (n = 344, 24.6%), followed by unspecified
(n = 138, 9.9%), colorectal (n = 131, 9.4%), brain (n = 98, 7.0%), lung (n = 84, 6.0%), pancreatic
(n = 61, 4.4%), gastrointestinal (n = 55, 3.9%), ovarian (n = 54, 3.9%), cervical (n = 42, 3.0%),
prostate (n = 34, 2.4%), lymphomas excluding non-Hodgkin (n = 30, 2.2%), and liver (n = 28,
2.0%) (see Table 3). This distribution of cancer types in some cases broadly tracks with US
mortality rates, including colorectal cancers, gastrointestinal cancers, lymphomas, and mela-
nomas. In other cases, US mortality rates were much higher than found in these campaigns,
including lung cancer, pancreatic cancers, liver cancer, leukemia, and prostate cancer. Breast,
brain, ovarian, and cervical cancer were much more common in these campaigns than inci-
dence and mortality rates in the US and studies of crowdfunding campaigns found (see
Table 4).
The most common CAM interventions sought in these campaigns were a range of dietary
supplements (n = 422, 30.2%). These supplements were described both in general terms and as
PLOS ONE Crowdfunding for complementary and alternative medicine
PLOS ONE | https://doi.org/10.1371/journal.pone.0242048 November 20, 2020 4 / 16
specific lists of items, as in one campaign that sought: “a variety of supplements such as Vit C,
D3, B17, oxygen, milk thistle for detoxing, among other more esoteric natural substances
geared at killing cancer cells or boosting the immune system”. Another common CAM inter-
vention was healthy food, better nutrition, organic food, or changes to diet (n = 293, 21.0%)
that were often justified in terms of supporting greater overall health or immunity. For
Table 1. Campaigner locations.
Campaigner Location Number of Campaigns Percentage of Campaigns
United States 1032 73.92%
Canada 165 11.82%








Costa Rica 1 0.07
Denmark 1 0.07








Fig 1. US campaigner locations.
https://doi.org/10.1371/journal.pone.0242048.g001
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example, one campaigner stated that “I believe we can heal all things with a healthy body . . .
and sure want to go that route”. Intravenous or high dose vitamin C (n = 276, 19.8%) appeared
commonly and was said, among other things, to have the effect of “giving me more energy.
Friends tell me my color is better”. As with dietary supplements, naturopathic interventions
(n = 226, 16.2%) were commonly praised as offering “holistic” care and in one case being
Fig 3. Worldwide campaigner locations.
https://doi.org/10.1371/journal.pone.0242048.g003
Fig 2. UK and Ireland campaigner locations.
https://doi.org/10.1371/journal.pone.0242048.g002
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provided by “a great, supportive naturopathic doctor that specializes in oncology with very
modern therapies from Europe”. Cannabis products including cannabidiol (CBD) and Rick
Simpson Oil (RSO) (n = 211, 15.1%) were frequently praised as offering more “natural” alter-
natives for pain relief and managing treatment side effects. This view is exemplified the cam-
paigner who wrote that “They gave her morphine the first time which tells me that BIG
PHARM has taken over so we are gonna try the Cbd route and maybe even marijuana route
for appetite and putting on the weight”. Other vitamins and minerals (n = 206, 14.8%) and
herbs and mushrooms (n = 159, 11.4%) joined dietary supplements in being said to have
immune and energy boosting properties.
Other commonly sought interventions included hyperbaric oxygen therapy (HBOT) and
other oxygen interventions (n = 146, 10.5%), immune system boosting interventions (n = 123,
8.8%), acupuncture (n = 121, 8.7%), detoxification, purges, cleanses, and chelation (n = 111,
8.0%), hyperthermia and other heat therapies (n = 110, 7.9%), juicing (n = 96, 6.9%), ozone
(n = 87, 6.2%), Gerson therapy (n = 82, 5.9%), and homeopathy (n = 76, 5.4%) (see Table 5).
The decision to pursue these products was characteristically justified in terms of undertaking a
“more natural and holistic approach” to cancer care; religious ideals such as “seeking alterna-
tive treatment, with a regimen of vitamins, jucing [sic] and whatever our Father God leads us
to”; the desire to explore “every option to treat his cancer”; and a “last resort” after the failure
of conventional treatment.
When these campaigns named treatment destinations and facilities, Mexico (n = 198,
41.9%), the US (n = 169, 35.7%), Germany (n = 37, 7.8%), and Canada (n = 19, 4.0%) were the
most common destination countries (see Table 6) (see Figs 4 and 5). The most commonly
named facility was CHIPSA Hospital in Tijuana, Mexico (n = 39, 11.0%), called “groundbreak-
ing” and “the premier Gerson Therapy Center”. Also located in Tijuana, Mexico, the Hope4-
Cancer Treatment Center (n = 33, 9.3%) was praised as “a wholly alternative, natural protocol
institute running for the last 30 years, with a staggering 98% success rate of full recovery from
stage 4 cancer”. As the name would suggest, the Gerson Institute in Tijuana, Mexico and Buda-
pest, Hungary (n = 23, 6.5%) was selected largely due to campaigners’ desire to access the Ger-
son therapy. The Immunity Therapy Center in Tijuana, Mexico (n = 15, 4.2%) was praised as
offering both integrative care and recognizing that there “are other choices beyond conven-
tional cancer treatments when chemotherapy, radiation, and traditional medicine do not
work”. Another Tijuana, Mexico clinic, Oasis of Hope (n = 14, 3.9%), was selected for “a holis-
tic atmosphere that addresses healing of the body, mind and spirit”. As with campaigners seek-
ing the Gerson therapy specifically, the campaigners seeking treatment at the Forsythe Cancer
Care Center in Reno, Nevada (n = 11, 3.1%) sought a specific treatment regimen, as “Dr For-
sythe’s treatment shows results of about 80% tumor shrinkage” (see Table 7).
While there were regional differences in the destination preferences that were driven in
part by geographic proximity, Mexico remained a global draw for campaigners. Among UK-
Table 2. Recipient cancer stage.
Cancer Stage # % Total % Listed
Not Listed 582 41.69 N/A
4 454 32.52 55.77
3 130 9.31 15.97
Metastatic/Spread/Late Stage 102 7.31 12.53
Terminal/Incurable/Inoperable 79 5.66 9.70
2 42 3.01 5.16
1 7 0.50 0.86
https://doi.org/10.1371/journal.pone.0242048.t002
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based campaigns stating a destination, Germany (n = 9, 29.0%) was the most popular destina-
tion, followed by Mexico (n = 6, 19.6%), the UK (n = 5, 16.1%), Turkey (n = 3, 9.7%), Latvia
Table 3. Cancer types and locations.











Lymphoma (including Hodgkin) 30 2.15
Liver 28 2.01





Non-Hodgkin’s Lymphoma 18 1.29
Multiple Myeloma 17 1.22
Throat 15 1.07
Kidney 14 1.00
Squamous Cell 14 1.00







Ewing’s Sarcoma 6 .43
Appendix 5 .36
Sarcoma (Undefined) 5 .36
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(n = 2, 6.5%), and 1 each for Canada, China, the Czech Republic, Poland, Spain, and Thailand.
Australian-based campaigns sought interventions in Mexico (n = 6, 30.0%), Thailand (n = 4,
20.0%), Australia (n = 3, 15.0%), New Zealand (n = 2, 10.0%) and 1 each for Ecuador, Ger-
many, Indonesia, Jamaica, and the US.
Discussion
These findings confirm an ongoing and very active presence of crowdfunding campaigns for
CAM cancer interventions on the GoFundMe platform. In some respects, the recipients of
these campaigns overlap with and help support the findings of other studies of people seeking
CAM interventions for cancer. Studies of these individuals have shown that they tend to have
late stage cancers. This was the case in our findings as well, with 65.4% of those discussing
their cancer stage describing themselves as having a stage 4 or terminal cancer diagnosis and
only 6.0% having a stage 1 or 2 diagnosis.
The cancer types and locations in our findings commonly tracked more closely with mor-
tality rates than incidence rates in the US, as with colorectal, gastrointestinal, lymphomas, mel-
anoma, kidney, and thyroid cancers, though pancreatic and liver and bile duct cancers more
closely tracked incidence rates. Previous studies of CAM usage for cancer have found that
women and people with breast cancer are more likely to seek CAM interventions. This was the
case with our findings as well, with breast cancer by far the most commonly described cancer
type, making up nearly a quarter of campaigns. Cancers in the female reproductive system
were also much more common than their incidence or mortality rates would suggest, includ-
ing ovarian and cervical cancer. At the same time, campaigns for people with prostate cancer
Table 4. Cancer types by incidence and mortality.
Cancer Type % of campaign recipients % incidence (US)1 % mortality (US) % cancer crowdfunding generally2
Breast 24.64 15.39 6.96 18.3
Unspecified 9.89 N/A N/A N/A
Colorectal 9.38 9.33 8.88 7.0
Brain 7.02 1.35 2.93 4.2
Lung 6.02 12.95 23.51 10.9
Pancreatic 4.37 3.22 7.54 5.0
Gastrointestinal 3.94 2.56 4.49 N/A
Ovarian 3.87 1.28 2.30 N/A
Cervical 3.01 0.75 0.70 N/A
Prostate 2.44 9.91 5.21 N/A
Lymphomas 3.44 4.67 3.46 N/A
Liver and Bile Duct 2.87 2.38 5.24 4.2
Soft Tissue Sarcoma 1.93 0.72 0.87 N/A
Leukemia 1.86 3.51 3.76 13.0
Uterine/Endometrial 1.43 3.51 2.00 N/A
Melanoma 1.36 5.47 1.19 N/A
Bladder 1.29 4.57 2.91 N/A
Multiple Myeloma 1.22 1.82 2.14 N/A
Kidney 1.00 4.19 2.43 N/A
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were much less common than incidence and mortality rates would suggest. This provides evi-
dence that people with breast cancer and cancers of the female reproductive system are more
likely to ask for crowdfunding support for CAM cancer interventions. In addition to breast
cancer, studies have identified melanoma and colorectal as common types among those seek
Table 5. CAM treatment sought.
CAM Treatment # %
Supplements (teas, antioxidants) 422 30.23
Food/Diet (organic, nutrition) 293 20.99
IV Vitamin C 276 19.77
Naturopathy 226 16.19
Cannabis (CBD, RSO, THC) 211 15.11
Vitamins and Minerals 206 14.76
Herbal Remedies (mushrooms) 159 11.39
Oxygen Treatments (HBOT) 146 10.46
Immune System Boosting 123 8.81
Acupuncture 121 8.67
Detox (purges, cleanses, chelation) 111 7.95
Hyperthermia (heat therapy) 110 7.88
Juicing 96 6.88
Ozone Treatments 87 6.23
Gerson Therapy 82 5.87
Unspecified Alternative Treatments (Holistic, Natural) 77 5.52
Homeopathy 76 5.44
Light Treatments (Infrared, Photodynamic, Lasers) 65 4.66
Alternative Chemotherapy (low does, IPT) 62 4.44
Electromagnetic Treatments (Radio, Rife, Bemer) 59 4.23
Essential Oils (aromatherapy) 52 3.72
Mistletoe (Iscador) 50 3.58
Vitamin B17 (Laetrile, apricot seeds) 50 3.58
Energy Healing (Reiki, Qigong) 47 3.37
Body Work (massage) 40 2.87
PH Balancing (alkaline water) 40 2.87
Ketogenic Diet 33 2.36
Traditional Chinese Medicine 27 1.93
Chiropractic Treatment 23 1.65
Coffee Enemas 23 1.65
Dendritic Cell Therapy 18 1.29
Lymphatic Massage 15 1.07
Stem Cell Treatment 13 .93
Faith Healing (Shamans) 11 .79
Hypothermia (Cryotherapy, Cold Treatment) 11 .79
Budwig Diet 9 .64
Meditation 9 .64
Ayurveda 6 .43
Sonodynamic (Sound) 6 .43
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CAM interventions. Colorectal cancer was the second most common named cancer type in
our findings and both cancer types were found at rates similar to those for cancer mortality
rates in the US.
Cancers of the brain were the third most common type in our findings and appeared at
more than twice the mortality rate in the US. These campaigns also appeared more commonly
than in a study of crowdfunding campaigns for both conventional and CAM cancer treat-
ments. Brain cancers have generally not been discussed in connection to CAM, though there is
evidence of interest in CAM modalities in people with this form of cancer in Switzerland [25].
Our findings suggest that this group warrants more exploration in relation to their interest in
CAM interventions.
Lung cancer counts for nearly a quarter of cancer mortality in the US and 10.9% of cancer
crowdfunding campaigns for both conventional and CAM interventions. However, only 6.0%
of campaigns in this study reported a diagnosis of lung cancer. This discrepancy could be due
to lower income levels and educational attainments among those with lung cancer, factors
associated with lower CAM use [26]. It is also possible that stigmatized medical conditions or
behaviours such as smoking appear less commonly in crowdfunding campaigns [27, 28].
Previous studies have shown that vitamins, minerals, and natural supplements are the most
commonly used CAM cancer interventions. This was the case in our findings as well, with die-
tary supplements and dietary modifications most common. Among those seeking vitamin and
Table 6. CAM provider location.



















New Zealand 2 0.43
Switzerland 2 0.43
Brazil 1 0.21
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mineral supplements, high dose vitamin C, typically received intravenously, stood out as being
highly sought after and, to a lesser degree, vitamin B17 or laetrile. Among supplements, cannabis
products were very common, including CBD and RSO, and mistletoe or Iscador. Common
CAM interventions outside of these categories included oxygen treatments and HBOT, hyper-
thermia, ozone treatments, and homeopathy. Gerson therapy has previously been flagged as a
common and potentially dangerous CAM treatment, including in crowdfunding campaigns.
This intervention was common here too. These interventions are generally not well supported by
evidence and can cause negative side effects and interact with conventional treatments [4, 29].
Fig 5. European CAM providers.
https://doi.org/10.1371/journal.pone.0242048.g005
Fig 4. North and Central America CAM providers.
https://doi.org/10.1371/journal.pone.0242048.g004
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A previous study of crowdfunding for CAM cancer interventions noted the Burzynski clinic
in Texas and the Hallwang Private Oncology Clinic in Germany as common destinations for
recipients. By comparison, our study found a very high concentration of destinations in Baja
California and, specifically, Tijuana, including CHIPSA Hospital, Hope4Cancer, the Gerson
Institute, the Immunity Therapy Center, and Oasis of Hope. These providers have been criti-
cized as offering ineffective and potentially dangerous interventions and for misleading mar-
keting practices [30]. While the Burzynski Clinic appeared in 1.6% of named providers, the
Hallwang Clinic appeared only once.
The single appearance of the Hallwang clinic in our findings was likely due to GoFundMe’s
decision in March, 2019 to ban campaigns for treatment at that clinic due to concerns with
whether campaigners were well informed about treatments offered there [31]. We suggest that
our findings could similarly be used to restrict campaigns for treatments at facilities that have
been linked to misleading information by providers or treatments with poor evidence of effi-
cacy and increased risks to people with cancer. Similarly, our findings can and should be used
to help crowdfunding platforms, clinicians, researchers, and patient advocates to identify
patient groups and CAM intervention types that deserve greater research and focused inter-
ventions including education campaigns. These findings can also be used to support efforts to
Table 7. CAM provider name.
Provider Name Number Percent of Named Providers
Other 114 32.02
CHIPSA Hospital 39 10.96
Hope4Cancer 33 9.27
Gerson Institute 23 6.46
Immunity Therapy Center 15 4.21
Oasis of Hope 14 3.93
Forsythe Cancer Care Center 11 3.09
Cancer Center for Healing 10 2.81
Hoxsey Biomedical Center 10 2.81
Northern Baja Gerson Center 10 2.81
Sanoviv Medical Institute 8 2.25
Burzynski Clinic 6 1.69
Verita Life 6 1.69
Arcadia Praxisklinik 5 1.40
Block Center for Integrative Cancer Treatment 4 1.12
Cancer Treatment Centers of America 4 1.12
EuroMed Foundation 4 1.12
Integrated Health Clinic 4 1.12
Port Moody Integrated Health 4 1.12
Riordan Clinic 4 1.12
San Diego Clinic 4 1.12
An Oasis of Hope 3 0.84
Angel Farms 3 0.84
ChemoThermia Oncology Center 3 0.84
Envita Medical Center 3 0.84
Issels Immuno-Oncology 3 0.84
Namaste Health Center 3 0.84
Optimum Health Institute 3 0.84
Utopia Wellness 3 0.84
https://doi.org/10.1371/journal.pone.0242048.t007
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further regulate the CAM sector, particularly in instances where specific interventions are
being offered for specific cancer types without evidentiary support and based on misleading
claims by providers. However, our findings also demonstrate the global nature of CAM provi-
sion, where clusters of providers can take advantage of international boundaries and benefit
from weaker regulatory oversight to offer CAM treatments to non-nationals.
This study faces several limitations. The information provided in crowdfunding campaigns
is self-reported and therefore may be incomplete or inaccurate. The campaign location is
attributed to the campaign organizer, who may be a different person and in a different location
than the campaign recipient. Campaigners and recipients are typically close friends and family,
however, reducing the impact of this limitation on understanding recipient locations. As we
captured campaign data at a single point in time, some campaigns initiated during the prior
year would have been previously closed and therefore not captured in our findings. Thus, the
overall number of crowdfunding campaigns for CAM cancer interventions is larger than that
reported here.
As our and others’ findings show, people with cancer seeking CAM interventions are
largely a very ill group of people. They are highly vulnerable to the harms of lost financial
resources due to ineffective interventions, negative side effects and drug interactions from
some CAM interventions, encouragement to forego palliative care, and lost and exploited
hope. These campaigners pass misinformation about the efficacy of CAM interventions to a
wide audience through highly compelling testimonials. These findings display a growing prob-
lem in the use and funding of CAM cancer interventions and, at the same time, an opportunity
for timely information about CAM usage and targeted interventions where justified.
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